BOUNDLESS BIO, INC. Payments of Stock Issuance Costs
BOUNDLESS BIO, INC. (BOLD) reported Payments of Stock Issuance Costs of $3.35 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-09
- BOUNDLESS BIO, INC. payments of stock issuance costs for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- BOUNDLESS BIO, INC. payments of stock issuance costs for the quarter ending 2024-09-30 was $13.00K.
- BOUNDLESS BIO, INC. payments of stock issuance costs for the quarter ending 2024-06-30 was $2.35M.
- BOUNDLESS BIO, INC. payments of stock issuance costs for the quarter ending 2024-03-31 was $983.00K.
- BOUNDLESS BIO, INC. payments of stock issuance costs for fiscal 2024 was $3.35M, a 71.22% increase from fiscal 2023.
- BOUNDLESS BIO, INC. payments of stock issuance costs for fiscal 2023 was $1.96M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $13.00K derived: sum of 2 quarters · filed 2026-03-09 | $2.37M derived: sum of 3 quarters · filed 2026-03-09 | $3.35M 10-K · filed 2026-03-09 |
| 2024-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.37M derived: sum of 2 quarters · filed 2025-11-05 | $3.35M 10-Q · filed 2025-11-05 | $4.77M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $3.34M 10-Q · filed 2025-08-05 | $4.76M derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | $983.00K 10-Q · filed 2025-05-09 | $2.41M derived: sum of 2 quarters · filed 2025-05-09 | ||
| 2023-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.96M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $533.00K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |